Home › Funds › Longaeva Partners L.P. › QURE
Longaeva Partners L.P. position in QURE
UNIQURE NV · Health Care
Longaeva Partners L.P. reported holding 804,594 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$37.1M, representing 0.85% of its reported portfolio and ranking #20 among its reported holdings. Longaeva Partners L.P. has disclosed QURE holdings in 2 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Longaeva Partners L.P.'s QURE position evolved
Longaeva Partners L.P. first disclosed a stake in QURE in Q3 2025 at 55,000 shares (US$3.2M). The position peaked in Q2 2026 at 804,594 shares, worth US$37.1M. Across 2 filings, Longaeva Partners L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 804,594 shares valued at US$37.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 55.00K | $3.21M | New |
| Q2 2026 | 804.59K | $37.06M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QURE and 13F data
QURE (UNIQURE NV) is a Health Care company. 64 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QURE
- Avoro Capital Advisors LLC 6.73M sh · $309.88M · Q2 2026
- RTW INVESTMENTS, LP 3.94M sh · $181.55M · Q2 2026
- ORBIMED ADVISORS LLC 1.81M sh · $83.25M · Q2 2026
- Boxer Capital Management, LLC 1.50M sh · $69.24M · Q2 2026
- MAK CAPITAL ONE LLC 1.23M sh · $56.75M · Q2 2026
- MPM BioImpact LLC 1.23M sh · $56.46M · Q2 2026
- Vestal Point Capital, LP 935.00K sh · $43.07M · Q2 2026
- Maverick Capital 925.38K sh · $42.62M · Q2 2026
- MAVERICK CAPITAL LTD 925.38K sh · $42.62M · Q2 2026
- Integral Health Asset Management, LLC 900.00K sh · $41.45M · Q2 2026
- Two Seas Capital LP 1.32M sh · $31.99M · Q3 2026
- First Turn Management, LLC 608.92K sh · $28.05M · Q2 2026
More on Longaeva Partners L.P.
FAQ
How long has Longaeva Partners L.P. held QURE?
Longaeva Partners L.P. has disclosed QURE holdings in 2 of the last 4 reported quarters, going back to Q3 2025.
What is Longaeva Partners L.P.'s current position in QURE?
As of Q2 2026, Longaeva Partners L.P. holds 804.59K shares of QURE (UNIQURE NV), valued at $37.06M, representing 0.85% of its reported portfolio and ranking #20.
Has Longaeva Partners L.P. been buying or selling QURE?
In the latest 13F filing (Q2 2026), Longaeva Partners L.P. newly opened its position in QURE. The position peaked in Q2 2026 at 804.59K shares.
Which other funds hold QURE?
Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.